|
|
|
|
Buck Institute for Age Research, Novato, California
Pharmacological studies suggest a role for CB1 cannabinoid receptors (CB1R) in regulating neurogenesis in the adult brain. To investigate this possibility, we measured neurogenesis by intraperitoneal injection of bromodeoxyuridine (BrdU), which labels newborn neurons, in wild-type and CB1R-knockout (CB1R-KO) mice. CB1R-KO mice showed reductions in the number of BrdU-labeled cells to
50% of wild-type (WT) levels in dentate gyrus and subventricular zone (SVZ), suggesting that CB1R activation promotes neurogenesis. To test this further, WT mice were given the CB1R antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboximide hydrochloride (SR141716A) before measuring neurogenesis with BrdU. SR141716A paradoxically increased the number of BrdU-labeled cells by
50% in SVZ; another CB1R antagonist, 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide (AM251), had a similar effect. To investigate this discrepancy, SR141716A was given to CB1R-KO mice, in which it still stimulated neurogenesis, indicating involvement of a non-CB1 receptor. Action at one such non-CB1, SR141716A-sensitive site, the VR1 vanilloid receptor, was tested by administering SR141716A to VR1-KO mice, in which the ability of SR141716A to enhance neurogenesis was abolished. Thus, CB1 and VR1 receptors both seem to have roles in regulating adult neurogenesis.
Address correspondence to: Dr. David A. Greenberg, Buck Institute for Age Research, 8001 Redwood Boulevard, Novato, CA 94945. E-mail: dgreenberg{at}buckinstitute.org
This article has been cited by other articles:
![]() |
J. Mulder, T. Aguado, E. Keimpema, K. Barabas, C. J. Ballester Rosado, L. Nguyen, K. Monory, G. Marsicano, V. Di Marzo, Y. L. Hurd, et al. Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning PNAS, June 24, 2008; 105(25): 8760 - 8765. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aguado, E. Romero, K. Monory, J. Palazuelos, M. Sendtner, G. Marsicano, B. Lutz, M. Guzman, and I. Galve-Roperh The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis J. Biol. Chem., August 17, 2007; 282(33): 23892 - 23898. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Galve-Roperh, T. Aguado, J. Palazuelos, and M. Guzman The Endocannabinoid System and Neurogenesis in Health and Disease Neuroscientist, April 1, 2007; 13(2): 109 - 114. [Abstract] [PDF] |
||||
![]() |
T. Aguado, A. Carracedo, B. Julien, G. Velasco, G. Milman, R. Mechoulam, L. Alvarez, M. Guzman, and I. Galve-Roperh Cannabinoids Induce Glioma Stem-like Cell Differentiation and Inhibit Gliomagenesis J. Biol. Chem., March 2, 2007; 282(9): 6854 - 6862. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kim, S. J. Won, X. O. Mao, C. Ledent, K. Jin, and D. A. Greenberg Role for Neuronal Nitric-Oxide Synthase in Cannabinoid-Induced Neurogenesis J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 150 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kim, S. J. Won, X. O. Mao, K. Jin, and D. A. Greenberg Molecular Mechanisms of Cannabinoid Protection from Neuronal Excitotoxicity Mol. Pharmacol., March 1, 2006; 69(3): 691 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aguado, J. Palazuelos, K. Monory, N. Stella, B. Cravatt, B. Lutz, G. Marsicano, Z. Kokaia, M. Guzman, and I. Galve-Roperh The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor Cells J. Neurosci., February 1, 2006; 26(5): 1551 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jin, M. LaFevre-Bernt, Y. Sun, S. Chen, J. Gafni, D. Crippen, A. Logvinova, C. A. Ross, D. A. Greenberg, and L. M. Ellerby FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease PNAS, December 13, 2005; 102(50): 18189 - 18194. [Abstract] [Full Text] [PDF] |
||||